Vimian is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health.
Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to animals and veterinary professionals around the world.
We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential areas within animal health: Specialty Pharma (www.nextmune.com), Diagnostics (www.indical.com), Veterinary Services (www.vetfamily.com) and MedTech (www.movora.com).
Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth.
We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact improving animal health.
Headquartered in Stockholm, Sweden, Vimian and our family of companies serve over 15,000 customers in +70 countries and employ more than 400 people.
Employees: 201-500
Founded date: 2021
Investors 2
Date | Name | Website |
- | Fidelio | fideliocap... |
- | Fidelio Ca... | fideliocap... |
Mentions in press and media 2
Date | Title | Description | Source |
24.08.2022 | Vimian’s Interim Report for the Second Quarter of 2022 | STOCKHOLM, SWEDEN / ACCESSWIRE / August 24, 2022 / Vimian Group (STO:VIMIAN) Solid performance in ch... | accesswire... |
02.08.2022 | Vimian Group Acquires Leading Online Platform for Veterinary... | STOCKHOLM, SWEDEN / ACCESSWIRE / August 2, 2022 / Vimian Group (STO:VIMIAN) Vimian Group has acquire... | accesswire... |